BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 34628998)

  • 1. Volumetric staging in radiotherapy for oropharyngeal cancers.
    Miszczyk M; Staniewska E; Jabłońska I; Lipka-Rajwa A; Stawiski K; Tarnawski R
    Tumori; 2022 Dec; 108(6):586-591. PubMed ID: 34628998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil-lymphocyte ratio complements volumetric staging as prognostic factor in patients treated with definitive radiotherapy for oropharyngeal cancer.
    Panje C; Riesterer O; Glanzmann C; Studer G
    BMC Cancer; 2017 Sep; 17(1):643. PubMed ID: 28893236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor volume as a prognostic marker in p16-positive and p16-negative oropharyngeal cancer patients treated with definitive intensity-modulated radiotherapy.
    Carpén T; Saarilahti K; Haglund C; Markkola A; Tarkkanen J; Hagström J; Mattila P; Mäkitie A
    Strahlenther Onkol; 2018 Aug; 194(8):759-770. PubMed ID: 29774396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radical (chemo)radiotherapy in oropharyngeal squamous cell carcinoma: Comparison of TNM 7th and 8th staging systems.
    De Felice F; Bird T; Michaelidou A; Thavaraj S; Odell E; Sandison A; Hall G; Morgan P; Lyons A; Cascarini L; Fry A; Oakley R; Simo R; Jeannon JP; Lei M; Guerrero Urbano T
    Radiother Oncol; 2020 Apr; 145():146-153. PubMed ID: 31981964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study.
    O'Sullivan B; Huang SH; Su J; Garden AS; Sturgis EM; Dahlstrom K; Lee N; Riaz N; Pei X; Koyfman SA; Adelstein D; Burkey BB; Friborg J; Kristensen CA; Gothelf AB; Hoebers F; Kremer B; Speel EJ; Bowles DW; Raben D; Karam SD; Yu E; Xu W
    Lancet Oncol; 2016 Apr; 17(4):440-451. PubMed ID: 26936027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the 8
    van Gysen K; Stevens M; Guo L; Jayamanne D; Veivers D; Wignall A; Pang L; Guminski A; Lee A; Hruby G; Macleod P; Taylor A; Eade T
    BMC Cancer; 2019 Jul; 19(1):674. PubMed ID: 31288767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the ICON-S staging for HPV-associated oropharyngeal carcinoma using a pre-defined treatment policy.
    Porceddu SV; Milne R; Brown E; Bernard A; Rahbari R; Cartmill B; Foote M; McGrath M; Coward J; Panizza B
    Oral Oncol; 2017 Mar; 66():81-86. PubMed ID: 28249652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of tumor volume in patients with stage III-IVA hypopharyngeal cancer without bulky lymph nodes treated with definitive concurrent chemoradiotherapy.
    Chen SW; Yang SN; Liang JA; Lin FJ; Tsai MH
    Head Neck; 2009 Jun; 31(6):709-16. PubMed ID: 19260114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Volumetric staging in oropharyngeal cancer patients treated with definitive IMRT.
    Studer G; Glanzmann C
    Oral Oncol; 2013 Mar; 49(3):269-76. PubMed ID: 23089460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
    Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
    Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The applicability of new TNM classification for humanpapilloma virus-related oropharyngeal cancer in the 8th edition of the AJCC/UICC TNM staging system in Japan: A single-centre study.
    Sano D; Yabuki K; Arai Y; Tanabe T; Chiba Y; Nishimura G; Takahashi H; Yamanaka S; Oridate N
    Auris Nasus Larynx; 2018 Jun; 45(3):558-565. PubMed ID: 28760331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of tumor volumetry in patients with locally advanced head-and-neck carcinoma (non-nasopharyngeal) treated by radiotherapy alone or combined radiochemotherapy in a randomized trial.
    Plataniotis GA; Theofanopoulou ME; Kalogera-Fountzila A; Haritanti A; Ciuleanou E; Ghilezan N; Zamboglou N; Dimitriadis A; Sofroniadis I; Fountzilas G
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1018-26. PubMed ID: 15234035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic value and initial exploratory research on TNM staging method of tumor deposits in stage III colon cancer].
    Qin Q; Yang L; Zhou AP; Wang JW; Zhong DS
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Dec; 22(12):1152-1158. PubMed ID: 31874531
    [No Abstract]   [Full Text] [Related]  

  • 14. Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume.
    Chao KS; Ozyigit G; Blanco AI; Thorstad WL; Deasy JO; Haughey BH; Spector GJ; Sessions DG
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):43-50. PubMed ID: 15093897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensity-modulated radiation therapy in oropharyngeal carcinoma: effect of tumor volume on clinical outcomes.
    Lok BH; Setton J; Caria N; Romanyshyn J; Wolden SL; Zelefsky MJ; Park J; Rowan N; Sherman EJ; Fury MG; Ho A; Pfister DG; Wong RJ; Shah JP; Kraus DH; Zhang Z; Schupak KD; Gelblum DY; Rao SD; Lee NY
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1851-7. PubMed ID: 21640497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Volumetric stratification of cT4 stage head and neck cancer.
    Studer G; Glanzmann C
    Strahlenther Onkol; 2013 Oct; 189(10):867-73. PubMed ID: 24002381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Confirmation of the eighth edition of the AJCC/UICC TNM staging system for HPV-mediated oropharyngeal cancer in Japan.
    Mizumachi T; Homma A; Sakashita T; Kano S; Hatakeyama H; Fukuda S
    Int J Clin Oncol; 2017 Aug; 22(4):682-689. PubMed ID: 28271391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A comparison of the 7th and 8th edition of the AJCC TNM staging systems for predicting survival in oropharyngeal cancer].
    Zhang YX; Liu MB; Huang H
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jul; 33(7):586-590. PubMed ID: 31327191
    [No Abstract]   [Full Text] [Related]  

  • 19. HPV impact on oropharyngeal cancer radiological staging: 7th vs 8th edition of AJCC TNM classification.
    Dal Cin E; Marcuzzo AV; Degrassi F; Volo T; Spinato R; Politi D; Capriotti V; Boscolo-Rizzo P; Tirelli G
    Clin Imaging; 2023 Jan; 93():39-45. PubMed ID: 36375362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
    Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.